ALX Oncology Holdings Inc. (ALXO)
NASDAQ·Healthcare·Biotechnology
$1.16
+0.52%
Mkt Cap $188.06M
Analyst Ratings
No recent rating data.
Price Target (7 analysts)
$17.90
Range $1.50 – $38.00
Implied Upside
+1441.8%
Consensus $17.90 vs current $1.16
NASDAQ·Healthcare·Biotechnology
$1.16
+0.52%
Mkt Cap $188.06M
No recent rating data.
Price Target (7 analysts)
$17.90
Range $1.50 – $38.00
+1441.8%
Consensus $17.90 vs current $1.16